Research Paper Volume 16, Issue 3 pp 2320—2339

Comprehensive analysis of ALG3 in pan-cancer and validation of ALG3 as an onco-immunological biomarker in breast cancer

class="figure-viewer-img"

Figure 8. ALG3 expression is associated with therapeutic responses in breast cancer. (A) The receiver operating characteristic (ROC) curve plot of the association between ALG3 expression and responses to chemotherapy in breast cancer who had pathology complete response. (B) The ROC curve plot of the association between ALG3 expression and responses to chemotherapy in breast cancer who had relapse-free survival at five years.